Medetomidine , 98% , 86347-14-0

CAS NO.：86347-14-0

Empirical Formula: C13H16N2

Molecular Weight: 200.28

MDL number:

EINECS: 1592732-453-0

PRODUCT Properties

• Boiling point: 381.9±11.0 °C(Predicted)
• Density: 1.053
• storage temp.: Sealed in dry,Room Temperature
• solubility: Soluble in DMSO
• pka: 14.29±0.10(Predicted)
• form: Powder
• color: White to off-white
• InChI: InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)
• InChIKey: CUHVIMMYOGQXCV-UHFFFAOYSA-N
• SMILES: C1NC(C(C2=CC=CC(C)=C2C)C)=CN=1

Description and Uses

Medetomidine is a synthetic compound used as a surgical anesthetic and analgesic. It is normally found as its hydrochloride salt, medetomidine hydrochloride. Medetomidine is an intravenously available alpha-2 adrenergic agonist. The drug has been developed by Orion Pharma. In the United States, it is currently approved for its veterinary use in dogs and distributed by Pfizer Animal Health. In Canada, medetomidine is distributed by Novartis Animal Health. The marketed product is a racemic mixture of two stereoisomers from which dexmedetomidine is the main active isomer.

Analgesic (veterinary); sedative (veterinary).

Safety

• Symbol(GHS): GHS06,GHS08,GHS09
• Signal word: Danger
• Hazard statements: H300-H330-H336-H370-H372-H410
• Precautionary statements: P264-P270-P301+P310-P321-P330-P405-P501-P260-P271-P284-P304+P340-P310-P320-P403+P233-P405-P501-P261-P271-P304+P340-P312-P403+P233-P405-P501-P260-P264-P270-P307+P311-P321-P405-P501-P260-P264-P270-P314-P501-P273-P391-P501